Glyprothiazol

Glyprothiazol

SCHEMBL1814714

CC(C)c1nnc(NS(=O)(=O)c2ccc(N)cc2)s1

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.71
HSD17B10 Q99714 1/20 0.71
LMNA P02545 2/20 0.68
AKT1 P31749 3/20 0.63
CA1 P00915 4/20 0.62
CA2 P00918 4/20 0.62
CA12 O43570 2/20 0.62
CA9 Q16790 2/20 0.62
CA3 P07451 1/20 0.62
CA6 P23280 1/20 0.62
CA5A P35218 1/20 0.62
CA14 Q9ULX7 1/20 0.62
CA5B Q9Y2D0 1/20 0.62
KDM4E B2RXH2 1/20 0.50
CYP2C9 P11712 1/20 0.50
EDNRA P25101 1/20 0.50
SLC6A4 P31645 1/20 0.50
ADRA1A P35348 1/20 0.50
PRMT6 Q96LA8 1/20 0.50
TDP1 Q9NUW8 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5398574 0.87 ALDH1A1 (0.73) ALDH1A1HSD17B10LMNACA1CA2
SCHEMBL5388827 0.86 ALDH1A1 (0.71) ALDH1A1HSD17B10LMNAAKT1CA1
SCHEMBL5401314 0.86 ALDH1A1 (0.71) ALDH1A1HSD17B10LMNACA1CA2
SCHEMBL5404610 0.86 ALDH1A1 (0.71) ALDH1A1HSD17B10LMNACA1
SCHEMBL3788763 0.85 ALDH1A1 (0.64) ALDH1A1HSD17B10LMNAAKT1CA1
SCHEMBL4594513 0.85 ALDH1A1 (0.67) ALDH1A1HSD17B10LMNAAKT1CA1
Hydrochloric Acid SCHEMBL3776921 0.84 ALDH1A1 (0.62) ALDH1A1HSD17B10LMNAAKT1CA1
Hydrochloric Acid SCHEMBL3776916 0.84 ALDH1A1 (0.65) ALDH1A1HSD17B10LMNAAKT1CA1
SCHEMBL5395237 0.83 ALDH1A1 (0.68) ALDH1A1HSD17B10LMNAAKT1CA1
SCHEMBL5401322 0.82 ALDH1A1 (0.67) ALDH1A1HSD17B10CA1CA2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120141232-A High maneuvering target interception method of lift wing unmanned aerial vehicle based on visual servo 北京航空航天大学 2025-06-13 CN claimed
WO-2025118611-A1 CARBON FOOTPRINT ACCOUNTING METHOD AND SYSTEM FOR POWER GRID MATERIAL PRODUCT BASED ON LCA 云南电网有限责任公司信息中心 2025-06-12 WO claimed
CN-118296797-A Interception/collision capacity force measuring method for sight line constraint 北京航空航天大学 2024-07-05 CN claimed
CN-118242933-A High-precision high-dynamic autonomous interception/collision method for aircraft 北京航空航天大学 2024-06-25 CN claimed
EP-4372095-A1 METHOD FOR PRODUCING PLASMID DNA USING ESCHERICHIA COLI Kaneka Corporation (JP) 2024-05-22 EP claimed
CN-114785474-A In-vehicle SOME/IP transmission method and device based on TSN time sensitive network 上海赫千电子科技有限公司 2022-07-22 CN claimed
EP-4741827-A2 DESORPTION ELECTROSPRAY IONISATION MASS SPECTROMETRY (\"DESI-MS\") AND DESORPTION ELECTROFLOW FOCUSING IONISATION (\"DEFFI-MS\") ANALYSIS OF BIOLOGICAL SAMPLES ON SWABS Micromass UK Limited (GB) 2026-05-13 EP disclosed
EP-3800657-B1 DESORPTION ELECTROSPRAY IONISATION MASS SPECTROMETRY (\"DESI-MS\") AND DESORPTION ELECTROFLOW FOCUSING IONISATION (\"DEFFI-MS\") ANALYSIS OF BIOLOGICAL SAMPLES ON SWABS MICROMASS LTD (GB) 2026-04-29 EP disclosed
EP-4437043-B1 COMPOSITIONS COMPRISING POLYARYLENE(ETHER)SULFONES BASF SE (DE) 2025-10-15 EP disclosed
CN-120141232-A High maneuvering target interception method of lift wing unmanned aerial vehicle based on visual servo 北京航空航天大学 2025-06-13 CN disclosed
WO-2025118611-A1 CARBON FOOTPRINT ACCOUNTING METHOD AND SYSTEM FOR POWER GRID MATERIAL PRODUCT BASED ON LCA 云南电网有限责任公司信息中心 2025-06-12 WO disclosed
US-12315714-B2 Tissue analysis by mass spectrometry or ion mobility spectrometry MICROMASS UK LIMITED (GB) 2025-05-27 US disclosed
CN-120009216-A Nondestructive testing method for organic silicon content of composite insulator umbrella cover material 清华大学深圳国际研究生院 2025-05-16 CN disclosed
EP-1341527-A1 PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX ALTANA Pharma AG (DE) 2003-09-10 EP disclosed
US-20020102215-A1 Diagnostic/therapeutic agents NYCOMED IMAGING AS 2002-08-01 US disclosed
US-20020102217-A1 Diagnostic/therapeutic agents NYCOMED IMAGING AS 2002-08-01 US disclosed
WO-2002045693-A1 PHARMACEUTICAL PREPARATION COMPRISING AN ACTIVE DISPERSED ON A MATRIX ALTANA PHARMA AG (DE) 2002-06-13 WO disclosed
US-6331289-B1 ULTRASOUND CONTRAST AGENTS, SUSPENSION IN AQUEOUS CARRIER LIQUID OF A REPORTER COMPRISING GAS-CONTAINING OR GAS-GENERATING MATERIAL, AGENT CAPABLE OF FORMING AT LEAST TWO TYPES OF BINDING PAIRS WITH TARGET; REPORTER BEING CONJUGATED NYCOMED IMAGING AS (NO) 2001-12-18 US disclosed
US-6264917-B1 MIXTURE OF GAS FILLED MICROBUBBLES AND RELEASING AGENT NYCOMED IMAGING AS (NO) 2001-07-24 US disclosed
US-6261537-B1 TARGETS AND ULTRASOUND DIAGNOSIS OF ACTIVE MATERIALS, AQUEOUS CARRIER LIQUIDS, CARRIERS AND FILM FORMING SURFACTANT PHOSPHATIDES NYCOMED IMAGING AS (NO) 2001-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020102215-A1 Diagnostic/therapeutic agents BID, FUS, FABP1 ALDH1A1 4459/4885HSD17B10 3826/4885LMNA 1552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.